GlobeNewswire

PaperCut Releases Version 18.0 with Print Room, Fab Lab Capabilities

Share

Education, professional service and commercial customers now able to manage specialty production and 3D printing capabilities under one easy-to-use solution

MELBOURNE, Australia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- PaperCut, a global software company, today announced the general availability of its PaperCut MF v18.0  software, bringing specialty production printing and 3D printing under one, easy to use software solution. Admins and operators can simply manage all specialty jobs, while also taking advantage of PaperCut's powerful cost management, security and user identification features with the new Job Ticketing capability.

The update connects in-house print rooms and fab labs at educational institutions, legal organizations, local governments, commercial organizations and hospitals to PaperCut's print management system. The Job Ticketing capability allows operators to accept specialty and 3D printing job submissions, such as laser cutting and prototype production, and track them through the production process while communicating the status to the requesting user.

"Until now, the lack of connection between our customers' general and specialty printing solutions - such as print rooms and 3D fab labs - has been a burden that cost them both time and money," said Chris Dance, co-founder and CEO of PaperCut. "To solve these problems, we've created a simple solution that will improve their specialty printing controls, security and payment options."

Because this feature falls under the same software individuals use to manage general office printing, users don't have to set up a separate profile or be re-authenticated to submit a print request, track its progression and flag questions or last-minute changes to the operator. This allows operators to spend less time managing processes-which are often manual and time-consuming-and more time driving adoption of their services and delivering high quality products for their customers.

Previously, organizations needing specialty prints lack affordable or efficient options-or both-to produce and manage jobs. Businesses would either have to use tedious, manual approaches to tracking and management, or purchase expensive software solutions limited in scope.

"The need for specialty print production is only increasing for organizations, especially universities," said Andy Slawetsky, President of Industry Analysts, Inc. "This market barely existed five years ago. Since then, there's been a rapid increase in demand resulting in a high unmet need for specialty print jobs to be managed and tracked under a unified capacity."

In addition to increased integration and workflow efficiency, the v18.0 release:

  • Reduces the need to purchase additional software packages for the print room
  • Supports all document formats and fonts on customers' personal, work and mobile devices.
  • Leverages customers' existing user permissions and accounting environment, charging for a job at any point straight back to their account.
  • Enables end users to submit a print room or 3D job through the streamlined web interface.
  • Builds a "personal touch" into the technology print room customers love, allowing for direct operator-customer communication and consistent updates on order progress.

Following PaperCut's true vendor-neutral approach, PaperCut MF v18.0 additional embedded solutions and updates have been made across a breadth of MFD devices, ensuring the platform stays up and running in conjunction with manufacturer progress. For full details on interoperability and product specs, please review the release notes, accessible here.

Availability

PaperCut MF v18.0 is now available to existing and future customers and partners. Pricing is licensed per print room as one standard product, with education and commercial customers having access to a single price exclusively as a feature of PaperCut.

About PaperCut Software
Around the world, workplaces are wrestling with printing costs and print management complexity. PaperCut is solving those problems, one workplace at a time. Since 1998, PaperCut has helped 50 million users in 175 countries save trillions of pages of paper. With PaperCut in their print environment, IT managers solve their nagging print problems once and for all. How? Its two software solutions - PaperCut MF and PaperCut NG - are cross-platform and vendor neutral. That means they work with any printer and any operating system. Plus, both solutions feature ground-breaking technology such as mobility print, secure print release, and rich reporting tools. Businesses of all shapes, sizes and industry benefit from the control, security and financial and environmental savings that PaperCut software was built for. Learn more at www.papercut.com.

Media Contact
Morgann Dulle
10Fold Communications for PaperCut
papercut@10fold.com
+1 (479) 586-1377




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Papercut Services North America LLC via Globenewswire

About GlobeNewswire

GlobeNewswire



Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPress release

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPress release

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPress release

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom